Bullish indicating open at $55-$60, IPO prices at $37
Investing.com - UBS has reiterated its Buy rating on Ormat Technologies (NYSE:ORA) with a price target of $105.00, representing potential upside from the current price of $86.68. According to InvestingPro data, the stock has shown strong momentum with a 37% gain over the past six months.
The rating confirmation was issued by UBS analyst Jon Windham, maintaining the firm’s positive outlook on the renewable energy company.
Ormat Technologies specializes in geothermal and recovered energy generation, with operations spanning multiple countries around the world.
The $105.00 price target suggests potential upside from the stock’s current trading levels, reflecting UBS’s confidence in the company’s growth prospects.
Ormat has been expanding its portfolio of geothermal and energy storage projects as demand for renewable energy solutions continues to grow globally.
In other recent news, Ormat Technologies reported second-quarter 2025 results that exceeded consensus expectations for both revenue and earnings. Following this announcement, Oppenheimer raised its price target for the company to $100, maintaining an Outperform rating. Additionally, Ormat Technologies completed the acquisition of the Blue Mountain geothermal power plant for $88 million, which operates under a power purchase agreement with NV Energy until the end of 2029. Analyst firm Baird upgraded Ormat Technologies’ stock rating from Neutral to Outperform, increasing the price target to $103, citing growing political support for geothermal power in the U.S. Jefferies also raised its price target to $97, describing favorable Senate draft legislation for geothermal energy and storage technologies. Barclays (LON:BARC) upgraded Ormat’s stock rating to Overweight and increased the price target to $86, highlighting the increasing demand for geothermal energy amid a significant U.S. power shortage. These developments reflect a strong growth outlook and increased interest in geothermal energy solutions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.